Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Osanto

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Experimental Hematology|October 11, 2003
Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumorsRenée M Y Barge, Susanne Osanto, W A F Erik Marijt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2012
Cediranib monotherapy in patients with advanced renal cell carcinoma: results of a randomised phase II studyPeter Mulders, Robert Hawkins, Paul Nathan, et al.
European Urology|February 3, 2012
Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 TrialCamillo Porta, Emiliano Calvo, Miguel A Climent, et al.
Thrombosis Research|March 25, 2014
Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infectionsF J Sherida H Woei-A-Jin, Willize E van der Starre, Margot E T Tesselaar, et al.
Virchows Archiv : an International Journal of Pathology|February 14, 2022
Alternative prostate cancer grading systems incorporating percent pattern 4/5 (IQ-Gleason) and cribriform architecture (cGrade) improve prediction of outcome after radical prostatectomyNeslisah Seyrek, Eva Hollemans, Eleni-Rosalina Andrinopoulou, et al.
Eclinicalmedicine|December 2, 2024
Health-related quality of life outcomes in randomized controlled trials in metastatic hormone-sensitive prostate cancer: a systematic reviewSusanne Osanto, Anne-Laurien van de Vliert-Bout, Cristina Alvarez Gomez de Segura, et al.
The Oncologist|July 12, 2021
Neoadjuvant Treatment with Angiogenesis-Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II StudyF J Sherida H Woei-A-Jin, Nir I Weijl, Mark C Burgmans, et al.
Cancer Immunology, Immunotherapy : CII|August 23, 2006
Functional CD8+ T cells infiltrate into nonsmall cell lung carcinomaElizabeth M E Verdegaal, Conny Hoogstraten, Maro H Sandel, et al.
Cancer Treatment Reviews|June 22, 2011
Multidisciplinary management of metastatic renal cell carcinoma in the era of targeted therapiesBernard Escudier, Susanne Osanto, Börje Ljungberg, et al.
Histopathology|October 27, 2021
Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patientsNeslisah Seyrek, Eva Hollemans, Susanne Osanto, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Experimental Hematology|October 11, 2003
Minimal GVHD following in-vitro T cell-depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumorsRenée M Y Barge, Susanne Osanto, W A F Erik Marijt, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2012
Cediranib monotherapy in patients with advanced renal cell carcinoma: results of a randomised phase II studyPeter Mulders, Robert Hawkins, Paul Nathan, et al.
European Urology|February 3, 2012
Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 TrialCamillo Porta, Emiliano Calvo, Miguel A Climent, et al.
Thrombosis Research|March 25, 2014
Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infectionsF J Sherida H Woei-A-Jin, Willize E van der Starre, Margot E T Tesselaar, et al.
Virchows Archiv : an International Journal of Pathology|February 14, 2022
Alternative prostate cancer grading systems incorporating percent pattern 4/5 (IQ-Gleason) and cribriform architecture (cGrade) improve prediction of outcome after radical prostatectomyNeslisah Seyrek, Eva Hollemans, Eleni-Rosalina Andrinopoulou, et al.
Eclinicalmedicine|December 2, 2024
Health-related quality of life outcomes in randomized controlled trials in metastatic hormone-sensitive prostate cancer: a systematic reviewSusanne Osanto, Anne-Laurien van de Vliert-Bout, Cristina Alvarez Gomez de Segura, et al.
The Oncologist|July 12, 2021
Neoadjuvant Treatment with Angiogenesis-Inhibitor Dovitinib Prior to Local Therapy in Hepatocellular Carcinoma: A Phase II StudyF J Sherida H Woei-A-Jin, Nir I Weijl, Mark C Burgmans, et al.
Cancer Immunology, Immunotherapy : CII|August 23, 2006
Functional CD8+ T cells infiltrate into nonsmall cell lung carcinomaElizabeth M E Verdegaal, Conny Hoogstraten, Maro H Sandel, et al.
Cancer Treatment Reviews|June 22, 2011
Multidisciplinary management of metastatic renal cell carcinoma in the era of targeted therapiesBernard Escudier, Susanne Osanto, Börje Ljungberg, et al.
Histopathology|October 27, 2021
Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patientsNeslisah Seyrek, Eva Hollemans, Susanne Osanto, et al.
Pageof 6